Dr. Thomas Diefenthal is the managing director of BioPark Regensburg GmbH.
BioPark Regensburg GmbH is a company of the city of Regensburg and part of the economic promotion. The core tasks of the firm include the promotion of biotechnology, medical technology, diagnostics & analytics as well as the health economy at Regensburg and the region. For this purpose, the company operates three laboratory buildings with a total area of 18,000 m² on the premises of the University of Regensburg, where currently 37 tenants with about 600 employees work. On the other hand, it coordinates the active cluster management of BioRegio Regensburg with currently 55 companies and ca. 4,000 employees in East Bavaria.
BioPark Regensburg GmbH, managing director
- Management of the technology and start-up center BioPark with 37 tenants and 600 employees on the university campus
- Cluster management of the BioRegio Regensburg, certified according to the European Cluster Excellence Initiative, with 55 companies and 4,000 employees
- Management of the project Healthcare Regensburg (health economy)
Cluster companies that already use AI, special AI working group with regional network partners that is already addressing this area.
Cooperation of companies with clinics, start-up ideas with FUTUR, projects of university and non-university institutions in the BioPark
Linking research and development (application-oriented ThinkTank)
Promotion of start-ups, initiation of cooperation (pilot service), working groups
Clinical diagnostics
I am a geneticist by training; for me, decoding the genomes was the basis for understanding AI.
Question 10: Do you personally find it easy or difficult to deal with topics that are related to AI?
It is becoming an increasingly complex science, the user and the public should be taken by hand to prevent fears, e.g. about genetic engineering.
The possibility of being able to offer faster, better and cheaper medical diagnostics and therapies.
Clinical precision diagnostics from a company in the BioPark is already on the market.
The chances of using AI are obvious. But in the clinical use in particular, there are still many unanswered questions, e.g. about protecting patient data.
The BioPark is located on the university premises to promote cooperation between the university and companies.
Research and application are two separate worlds with different needs. The technology transfer must be professionalized in order to bring both together.
Thank you for taking the time to answer these questions. We wish you a nice day!
Thank you for taking the time to answer these questions. We wish you a nice day!